JP Stock MarketDetailed Quotes

3540 CI Medical

Watchlist
  • 881
  • -2-0.23%
20min DelayNot Open Jan 7 15:30 JST
44.05BMarket Cap21.15P/E (Static)

CI Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
10.47%12.37B
8.61%11.95B
6.38%45.63B
4.88%11.98B
9.01%11.45B
6.18%11.2B
5.59%11B
4.09%42.89B
7.71%11.42B
3.13%10.51B
Cost of revenue
13.04%9.18B
9.43%8.91B
7.74%33.63B
4.42%8.98B
9.04%8.38B
6.56%8.12B
11.50%8.15B
5.47%31.22B
10.60%8.6B
4.07%7.69B
Gross profit
3.64%3.19B
6.28%3.03B
2.76%11.99B
6.23%3B
8.91%3.07B
5.27%3.08B
-8.33%2.85B
0.58%11.67B
-0.21%2.82B
0.64%2.82B
Operating expense
24.81%2.61B
27.01%2.62B
17.22%9B
27.52%2.56B
16.26%2.29B
10.63%2.09B
13.77%2.07B
8.47%7.68B
7.97%2.01B
9.76%1.97B
Operating profit
-41.40%576M
-48.22%407M
-25.08%2.99B
-46.02%441M
-8.13%780M
-4.56%983M
-39.31%786M
-11.78%3.99B
-15.86%817M
-15.61%849M
Net non-operating interest income (expenses)
0.00%1M
-40.00%3M
-20.00%20M
0.00%3M
266.67%11M
-85.71%1M
-58.33%5M
19.05%25M
0.00%3M
-50.00%3M
Non-operating interest income
250.00%14M
28.57%9M
19.35%37M
66.67%10M
166.67%16M
-42.86%4M
-41.67%7M
47.62%31M
100.00%6M
0.00%6M
Non-operating interest expense
333.33%13M
200.00%6M
183.33%17M
133.33%7M
--5M
--3M
--2M
--6M
--3M
----
Net investment income
-1,500.00%-14M
59.26%-11M
13.33%-13M
266.67%11M
-71.43%2M
104.35%1M
-1,250.00%-27M
-287.50%-15M
150.00%3M
40.00%7M
Gain(Loss) on financial instruments designated as cash flow hedges
0
0
200.00%164M
0
-6M
103M
67M
-164M
-164M
0
Gain(Loss) on derecognition of available-for-sale financial assets
-47.83%-34M
54.05%-17M
-62.16%-60M
0
0
-64.29%-23M
-37M
64.76%-37M
23.33%-23M
0
Income from associates and other participating interests
-13M
-9M
51M
0
0
0
Special income (charges)
-2M
3M
-51M
-51M
0
0
0
0
0
0
Less:Other special charges
--2M
---3M
--51M
----
----
----
----
----
----
----
Other non-operating income (expenses)
14.29%16M
-20.00%16M
54.72%82M
111.76%36M
-47.83%12M
100.00%14M
233.33%20M
8.16%53M
142.86%17M
130.00%23M
Income before tax
-51.07%528M
-51.72%393M
-17.32%3.18B
-24.42%492M
-9.41%799M
7.26%1.08B
-37.96%814M
-10.13%3.85B
-29.62%651M
-11.98%882M
Income tax
-48.64%189M
-51.85%143M
-18.25%1.08B
-36.61%142M
-11.22%277M
5.75%368M
-32.81%297M
-9.43%1.33B
-28.66%224M
-9.04%312M
Net income
-52.53%338M
-51.55%250M
-16.84%2.1B
-17.84%350M
-8.60%521M
8.04%712M
-40.62%516M
-10.50%2.52B
-30.28%426M
-13.51%570M
Net income continuous operations
-52.32%339M
-51.64%250M
-16.83%2.1B
-18.03%350M
-8.42%522M
8.05%711M
-40.57%517M
-10.49%2.53B
-30.11%427M
-13.51%570M
Noncontrolling interests
60.00%8M
150.00%2M
633.33%16M
333.33%7M
8M
5M
-4M
-3M
-3M
0
Net income attributable to the company
-53.19%330M
-52.59%247M
-17.41%2.08B
-18.91%343M
-10.00%513M
6.98%705M
-40.05%521M
-10.60%2.52B
-30.77%423M
-13.51%570M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-53.19%330M
-52.59%247M
-17.41%2.08B
-18.91%343M
-10.00%513M
6.98%705M
-40.05%521M
-10.60%2.52B
-30.77%423M
-13.51%570M
Gross dividend payment
Basic earnings per share
-53.24%6.598
-52.48%4.952
-17.41%41.654
-18.98%6.864
-9.92%10.26
6.99%14.11
-40.05%10.42
-10.61%50.432
-30.75%8.472
-13.58%11.39
Diluted earnings per share
-53.21%6.598
-52.48%4.952
-17.41%41.654
-18.91%6.8601
-9.92%10.26
6.98%14.1002
-40.05%10.42
-10.61%50.432
-30.77%8.4601
-13.58%11.39
Dividend per share
0
0
0.00%5.044
0.00%5.044
0
0
0
-10.60%5.044
-10.60%5.044
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 10.47%12.37B8.61%11.95B6.38%45.63B4.88%11.98B9.01%11.45B6.18%11.2B5.59%11B4.09%42.89B7.71%11.42B3.13%10.51B
Cost of revenue 13.04%9.18B9.43%8.91B7.74%33.63B4.42%8.98B9.04%8.38B6.56%8.12B11.50%8.15B5.47%31.22B10.60%8.6B4.07%7.69B
Gross profit 3.64%3.19B6.28%3.03B2.76%11.99B6.23%3B8.91%3.07B5.27%3.08B-8.33%2.85B0.58%11.67B-0.21%2.82B0.64%2.82B
Operating expense 24.81%2.61B27.01%2.62B17.22%9B27.52%2.56B16.26%2.29B10.63%2.09B13.77%2.07B8.47%7.68B7.97%2.01B9.76%1.97B
Operating profit -41.40%576M-48.22%407M-25.08%2.99B-46.02%441M-8.13%780M-4.56%983M-39.31%786M-11.78%3.99B-15.86%817M-15.61%849M
Net non-operating interest income (expenses) 0.00%1M-40.00%3M-20.00%20M0.00%3M266.67%11M-85.71%1M-58.33%5M19.05%25M0.00%3M-50.00%3M
Non-operating interest income 250.00%14M28.57%9M19.35%37M66.67%10M166.67%16M-42.86%4M-41.67%7M47.62%31M100.00%6M0.00%6M
Non-operating interest expense 333.33%13M200.00%6M183.33%17M133.33%7M--5M--3M--2M--6M--3M----
Net investment income -1,500.00%-14M59.26%-11M13.33%-13M266.67%11M-71.43%2M104.35%1M-1,250.00%-27M-287.50%-15M150.00%3M40.00%7M
Gain(Loss) on financial instruments designated as cash flow hedges 00200.00%164M0-6M103M67M-164M-164M0
Gain(Loss) on derecognition of available-for-sale financial assets -47.83%-34M54.05%-17M-62.16%-60M00-64.29%-23M-37M64.76%-37M23.33%-23M0
Income from associates and other participating interests -13M-9M51M000
Special income (charges) -2M3M-51M-51M000000
Less:Other special charges --2M---3M--51M----------------------------
Other non-operating income (expenses) 14.29%16M-20.00%16M54.72%82M111.76%36M-47.83%12M100.00%14M233.33%20M8.16%53M142.86%17M130.00%23M
Income before tax -51.07%528M-51.72%393M-17.32%3.18B-24.42%492M-9.41%799M7.26%1.08B-37.96%814M-10.13%3.85B-29.62%651M-11.98%882M
Income tax -48.64%189M-51.85%143M-18.25%1.08B-36.61%142M-11.22%277M5.75%368M-32.81%297M-9.43%1.33B-28.66%224M-9.04%312M
Net income -52.53%338M-51.55%250M-16.84%2.1B-17.84%350M-8.60%521M8.04%712M-40.62%516M-10.50%2.52B-30.28%426M-13.51%570M
Net income continuous operations -52.32%339M-51.64%250M-16.83%2.1B-18.03%350M-8.42%522M8.05%711M-40.57%517M-10.49%2.53B-30.11%427M-13.51%570M
Noncontrolling interests 60.00%8M150.00%2M633.33%16M333.33%7M8M5M-4M-3M-3M0
Net income attributable to the company -53.19%330M-52.59%247M-17.41%2.08B-18.91%343M-10.00%513M6.98%705M-40.05%521M-10.60%2.52B-30.77%423M-13.51%570M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -53.19%330M-52.59%247M-17.41%2.08B-18.91%343M-10.00%513M6.98%705M-40.05%521M-10.60%2.52B-30.77%423M-13.51%570M
Gross dividend payment
Basic earnings per share -53.24%6.598-52.48%4.952-17.41%41.654-18.98%6.864-9.92%10.266.99%14.11-40.05%10.42-10.61%50.432-30.75%8.472-13.58%11.39
Diluted earnings per share -53.21%6.598-52.48%4.952-17.41%41.654-18.91%6.8601-9.92%10.266.98%14.1002-40.05%10.42-10.61%50.432-30.77%8.4601-13.58%11.39
Dividend per share 000.00%5.0440.00%5.044000-10.60%5.044-10.60%5.0440
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Tecnisco
2962
333 +31.62%
EduLab
4427
269 +28.71%
Fundely
3137
380 +26.67%
NF Holdings
6864
1530 +24.39%
Fujitsu General
6755
2750 +20.99%

See the daily top gainer.